Immunology

Top Story

Minimal immunosuppression recommended in transplant setting

April 20, 2017

AMSTERDAM — Understanding the impacts of fibrosis, drug–drug interactions with direct-acting antiviral therapies, and the pitfalls of immunosuppression can aid clinicians in treating liver transplantation candidates or recipients, according to data presented at the International Liver Congress.

Michael Charlton, MD, a transplant hepatologist and director of the Intermountain Transplant and Regenerative Medicine Center, said that the frequency of wait-listing for transplantation for patients with HCV has decreased considerably in recent years. “The indication is now highest for alcohol use,” he said. “The indications for NASH have remained relatively stable.”

In the Journals Plus

Most immune globulin products ineffective for hepatitis A prophylaxis

January 10, 2017
A recent letter published in JAMA Internal Medicine reports two of nine human immune globulin products tested for hepatitis A prophylaxis efficacy just meet the minimal
In the Journals

Permanent drug withdrawal observed in patients with autoimmune hepatitis

March 28, 2014
Permanent drug withdrawal was an achievable treatment-free outcome and varied widely for patients with autoimmune hepatitis, according to a meta-analysis. Researchers…
Industry News

Hepatology group urges UK’s health service to combat rise in liver disease

March 26, 2014
Members of the All-Party Parliamentary Hepatology Group have asked the National Health Service in the United Kingdom to show more concern about the rise of liver…
CME

HCV Updates and Case Challenges for the Rapidly Changing Landscape

This activity is supported by an educational grant from Merck & Co., Inc.

In the past few years, significant progress has been made in the treatment of chronic hepatitis C virus (HCV). Highly…
More »
GI Bookshelf

Chapter 3: Barrier Function And Theimmune Response

From Probiotics: A Clinical Guide
More »
Featured
International Liver Congress

International Liver Congress

Video
Meeting News

VIDEO: Liver disease topics discussed at DDW include HCV, NAFLD, statins

May 12, 2017
More »
Meeting News

Minimal immunosuppression recommended in transplant setting

April 20, 2017
AMSTERDAM — Understanding the impacts of fibrosis, drug–drug interactions with direct-acting antiviral therapies, and the pitfalls of…

In the Journals Plus

Most immune globulin products ineffective for hepatitis A prophylaxis

January 10, 2017
A recent letter published in JAMA Internal Medicine reports two of nine human immune globulin products tested for hepatitis A prophylaxis efficacy

In the Journals

Permanent drug withdrawal observed in patients with autoimmune hepatitis

March 28, 2014
Permanent drug withdrawal was an achievable treatment-free outcome and varied widely for patients with autoimmune hepatitis, according to a…

Industry News

Hepatology group urges UK’s health service to combat rise in liver disease

March 26, 2014
Members of the All-Party Parliamentary Hepatology Group have asked the National Health Service in the United Kingdom to show more concern about the…

In the Journals

Chronic kidney disease led to poor response to HBV vaccine

February 18, 2014
Hemodialysis patients with chronic kidney disease produce inferior immune responses to hepatitis B vaccine, with 41% of dialysis patients classified…

In the Journals

Acute renal failure predicts mortality in cirrhotic patients with spontaneous bacterial peritonitis

June 20, 2012
Acute renal failure better determined mortality rates in patients with cirrhosis and spontaneous bacterial peritonitis than renal impairment and…

Meeting News Coverage

Mediterranean diet improves liver health independent of weight loss

November 7, 2011
SAN FRANCISCO — A diet high in omega-3 fatty acids improved liver health in subjects with nonalcoholic fatty liver disease, according to a…

More Headlines »
Advertisement
Advertisement